Shanghai Conant Optical Co., Ltd. provided unaudited consolidated earnings guidance for the year ended 31 December 2023. For the year, the group expects its net profit attributable to shareholders for the year ended 31 December 2023 to increase by no less than 30% compared with that for the year ended 31 December 2022. The increase was mainly attributable to (i) an increase in revenue as a result of an increased business scale of resin spectacle lens; (ii) an increase in gross profit due to an increase in the gross profit margin; (iii) an increase in exchange gain arising from the appreciation of U.S. dollar against Renminbi; and (iv) a decrease in finance costs due to the repayment of interest-bearing bank borrowings and the reduction in the interest rates of bank borrowing.
Shanghai Conant Optical Co., Ltd.
Equities
2276
CNE100004Z14
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.74 HKD | -1.91% | -4.48% | +23.80% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.80% | 486M | |
+12.72% | 99.81B | |
+11.70% | 39.88B | |
-1.26% | 18.57B | |
-13.68% | 2.42B | |
-10.21% | 1.5B | |
+24.72% | 1.19B | |
-33.16% | 778M | |
-35.31% | 752M | |
-7.40% | 671M |
- Stock Market
- Equities
- 2276 Stock
- News Shanghai Conant Optical Co., Ltd.
- Shanghai Conant Optical Co., Ltd. Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023